Biotech · Private company · Charleston, SC, US
Loxigen, Inc.
Track this companyFree. Adds Loxigen, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- Developing novel LOX inhibitors to target chemotherapy resistant TNBCFiscal year 2025 · $1.1MNIH RePORTER 5R42CA275622-03 · fetched Nov 12, 2026
- Developing novel LOX inhibitors to target chemotherapy resistant TNBCFiscal year 2024 · $992.9KNIH RePORTER 4R42CA275622-02 · fetched Nov 12, 2026